person · Reporting owner

Foster Michael Curtis

Disclosed activity across 1 company

Tapewire entity: 140379
SEC CIK: 0001850411

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Alignment Healthcare, Inc.ALHC · Entity 4269	Chief Legal Officer	March 25, 2021	April 08, 2021

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Alignment Healthcare, Inc.

Report date March 25, 2021 · Filed April 08, 2021

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common Stock, par value $0.001 per share ("Common Stock")SEC Table I · non-derivative	Direct	1,132,692	Reported balance After 2021-03-25 transaction · row 1 1 source row Row 1 · 2021-03-25 · Grant · Acquired 27,500 · Balance 1,132,692 F1: Represents 27,500 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of Alignment Healthcare, Inc. (the "Company"), that will vest 25% on the first four anniversaries of the initial vesting date. The securities covered by such transaction were previously included on Mr. Foster's Form 3.
Common StockSEC Table I · non-derivative	Direct	1,081,849	Reported balance After 2021-04-06 transaction · row 2 1 source row Row 2 · 2021-04-06 · Sale · Disposed 50,843 · Balance 1,081,849 F2: Represents 50,843 shares of Common Stock sold pursuant to the partial exercise by the underwriters of their over-allotment option after the closing of the Company's initial public offering, at a price of $16.83 (net of underwriting discount).
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.00 · Expires 2031-03-25	Direct	346,296	Reported balance After 2021-03-25 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2021-03-25 · Grant · Acquired 346,296 · Balance 346,296 F3: Represents 346,296 options to purchase Common Stock of the Company at the initial public offering price. The securities covered by such transaction were previously included on Mr. Foster's Form 3. F4: Vest 25% on the first four anniversaries of the initial vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: Represents 27,500 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of Alignment Healthcare, Inc. (the "Company"), that will vest 25% on the first four anniversaries of the initial vesting date. The securities covered by such transaction were previously included on Mr. Foster's Form 3.

F2: Represents 50,843 shares of Common Stock sold pursuant to the partial exercise by the underwriters of their over-allotment option after the closing of the Company's initial public offering, at a price of $16.83 (net of underwriting discount).

F3: Represents 346,296 options to purchase Common Stock of the Company at the initial public offering price. The securities covered by such transaction were previously included on Mr. Foster's Form 3.

F4: Vest 25% on the first four anniversaries of the initial vesting date.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
April 06, 2021 Filed Apr 8, 2021 20:38 UTC	Alignment Healthcare, Inc. ALHC · Entity 4269	SaleCommon Stock	50,843	$16.83	$855,687.69	Disclosure SEC source: 0000899243-21-015447 · doc4.xml · nonDerivative · entry 2 Foster Michael Curtis · CIK 0001850411 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,081,849 F2 · kind: Represents 50,843 shares of Common Stock sold pursuant to the partial exercise by the underwriters of their over-allotment option after the closing of the Company's initial public offering, at a price of $16.83 (net of underwriting discount). Read SEC document
March 25, 2021 Filed Apr 8, 2021 20:38 UTC	Alignment Healthcare, Inc. ALHC · Entity 4269	GrantStock Option (right to buy) · Derivative	346,296	$0.00 Strike: $18.00	$0.00	Disclosure SEC source: 0000899243-21-015447 · doc4.xml · derivative · entry 3 Foster Michael Curtis · CIK 0001850411 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 346,296 Underlying: Common Stock · 346,296 shares Expires 2031-03-25 F3 · kind: Represents 346,296 options to purchase Common Stock of the Company at the initial public offering price. The securities covered by such transaction were previously included on Mr. Foster's Form 3. F4 · derivative.exercise_date: Vest 25% on the first four anniversaries of the initial vesting date. Read SEC document
March 25, 2021 Filed Apr 8, 2021 20:38 UTC	Alignment Healthcare, Inc. ALHC · Entity 4269	GrantCommon Stock, par value $0.001 per share ("Common Stock")	27,500	$0.00	$0.00	Disclosure SEC source: 0000899243-21-015447 · doc4.xml · nonDerivative · entry 1 Foster Michael Curtis · CIK 0001850411 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,132,692 F1 · kind: Represents 27,500 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of Alignment Healthcare, Inc. (the "Company"), that will vest 25% on the first four anniversaries of the initial vesting date. The securities covered by such transaction were previously included on Mr. Foster's Form 3. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.